Earnings

Xylem Lowers FY2026 Adj EPS Guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 Est; Lowers FY2026 Sales Guidance from $9.200B to $8.950B vs $9.191B Est

Oct 27, 2026 · 06:55 AM ET· updated 1h ago

Xylem (NYSE:XYL) lowers FY2026 Adj EPS guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 analyst estimate. Lowers FY2026 sales outlook from $9.200 billion to $8.950 billion vs $9.191 billion estimate.

Why It Matters

Xylem told investors it will make less money and sell less stuff next year. When a company lowers its promises, watch to see if business is slowing down.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

XYL99.05

-9.19 (-8.49%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.